Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
Submitted by
admin
on August 17, 2018 - 9:56am
Source:
CP Wire
News Tags:
Novo Nordisk
M&A
insulin
Ziylo
Headline:
Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
snippet:
The acquisition supports Novo Nordisk's goal to develop glucose responsive insulins
Upfront payment and contingent earn-outs and milestones could exceed $800 million
Do Not Allow Advertisers to Use My Personal information
